Phase II study of erlotinib with concurrent whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 2031-2031
◽
Keyword(s):
Phase Ii
◽